Small leucine zipper protein (sLZIP) negatively regulates skeletal muscle differentiation via interaction with α-actinin-4

Journal of Biological Chemistry

Volumn 289, Issue 8, 2014, Pages 4969-4979

  An, Hyoung Tae ^a   Kim, Jeonghan ^a   Yoo, Seungmin ^a   Ko, Jesang ^a  

^a Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTORS;

LEUCINE ZIPPER PROTEINS; MUSCLE DISEASE; MYOGENESIS; REGULATORY FACTORS; REGULATORY MECHANISM; SKELETAL MUSCLE DIFFERENTIATION; THERAPEUTIC TARGETS;

MUSCLE;

ALPHA ACTININ 4; LEUCINE ZIPPER PROTEIN; MYOCYTE ENHANCER FACTOR 2; MYOGENIN; SMALL LEUCINE ZIPPER PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL FRACTIONATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MRF GENE; MURINAE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SKELETAL MUSCLE; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

ACTININ-4; DIFFERENTIATION; GENE TRANSCRIPTION; MUSCLE; MYOGENESIS; SLZIP; TRANSCRIPTION REPRESSOR;

ACTININ; AMINO ACID SEQUENCE; ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HUMANS; MEF2 TRANSCRIPTION FACTORS; MICE; MOLECULAR SEQUENCE DATA; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; ORGAN SPECIFICITY; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTIONAL ACTIVATION;

EID: 84894431930     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.515395     Document Type: Article

References (36)

1. Kang, H., Kim, Y. S., and Ko, J. (2009) A novel isoform of human LZIP negatively regulates the transactivation of the glucocorticoid receptor. Mol. Endocrinol. 23, 1746-1757
2. Kang, H., Jang, S. W., and Ko, J. (2011) Human leucine zipper protein sLZIP induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9. J. Biol. Chem. 286, 42072-42081
3. Jang, S. Y., Jang, S. W., and Ko, J. (2012) Regulation of ADP-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migration. Cancer Lett. 314, 185-197
4. Honda, K., Yamada, T., Endo, R., Ino, Y., Gotoh, M., Tsuda, H., Yamada, Y., Chiba, H., and Hirohashi, S. (1998) Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J. Cell Biol. 140, 1383-1393
5. Passaquin, A. C., Lhote, P., and Rüegg, U. T. (1998) Calcium influx inhibition by steroids and analogs in C2C12 skeletal muscle cells. Br. J. Pharmacol. 124, 1751-1759
6. Takada, F., Vander Woude, D. L., Tong, H. Q., Thompson, T. G., Watkins, S. C., Kunkel, L. M., and Beggs, A. H. (2001) Myozenin: an actinin-and filamin-binding protein of skeletal muscle Z lines. Proc. Natl. Acad. Sci. U.S.A. 98, 1595-1600
7. Millake, D. B., Blanchard, A. D., Patel, B., and Critchley, D. R. (1989) The cDNA sequence of a human placental actinin. Nucleic Acids Res. 17, 6725
8. Youssoufian, H., McAfee, M., and Kwiatkowski, D. J. (1990) Cloning and chromosomal localization of the human cytoskeletal actinin gene reveals linkage to the spectrin gene. Am. J. Hum. Genet. 47, 62-72
9. Hayashida, Y., Honda, K., Idogawa, M., Ino, Y., Ono, M., Tsuchida, A., Aoki, T., Hirohashi, S., and Yamada, T. (2005) E-cadherin regulates the association between catenin and actinin-4. Cancer Res. 65, 8836-8845
10. Honda, K., Yamada, T., Hayashida, Y., Idogawa, M., Sato, S., Hasegawa, F., Ino, Y., Ono, M., and Hirohashi, S. (2005) Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gastroenterology 128, 51-62
11. Shao, H., Wang, J. H., Pollak, M. R., and Wells, A. (2010) Actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts. PloS One 5, e13921
12. Goffart, S., Franko, A., Clemen, C. S., and Wiesner, R. J. (2006) Actinin 4 and BAT1 interaction with the cytochrome c promoter upon skeletal muscle differentiation. Curr. Genet. 49, 125-135
13. Kumeta, M., Yoshimura, S. H., Harata, M., and Takeyasu, K. (2010) Molecular mechanisms underlying nucleocytoplasmic shuttling of actinin-4. J. Cell Sci. 123, 1020-1030
14. Chakraborty, S., Reineke, E. L., Lam, M., Li, X., Liu, Y., Gao, C., Khurana, S., and Kao, H. Y. (2006) Actinin 4 potentiates myocyte enhancer factor-2 transcription activity by antagonizing histone deacetylase7. J. Biol. Chem. 281, 35070-35080
15. Delgado, I., Huang, X., Jones, S., Zhang, L., Hatcher, R., Gao, B., and Zhang, P. (2003) Dynamic gene expression during the onset of myoblast differentiation in vitro. Genomics 82, 109-121
16. Horlick, R. A., and Benfield, P. A. (1989) The upstream muscle-specific enhancer of the rat muscle creatine kinase gene is composed of multiple elements. Mol. Cell. Biol. 9, 2396-2413
17. Miller, J. B. (1990) Myogenic programs of mouse muscle cell lines: expression of myosin heavy chain isoforms, MyoD1, and myogenin. J. Cell Biol. 111, 1149-1159
18. Sumitani, S., Goya, K., Testa, J. R., Kouhara, H., and Kasayama, S. (2002) Akt1 and Akt2 differently regulate muscle creatine kinase and myogenin gene transcription in insulin-induced differentiation of C2C12 myoblasts. Endocrinology 143, 820-828
19. Black, B. L., and Olson, E. N. (1998) Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14, 167-196
20. Suzuki, E., Guo, K., Kolman, M., Yu, Y. T., and Walsh, K. (1995) Serum induction of MEF2/RSRF expression in vascular myocytes is mediated at the level of translation. Mol. Cell. Biol. 15, 3415-3423
21. Ma, K., Chan, J. K., Zhu, G., and Wu, Z. (2005) Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol. Cell. Biol. 25, 3575-3582
22. Wright, W. E., Sassoon, D. A., and Lin, V. K. (1989) Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56, 607-617
23. Bessman, S. P., and Geiger, P. J. (1981) Transport of energy in muscle: the phosphorylcreatine shuttle. Science 211, 448-452
24. Tombes, R. M., and Shapiro, B. M. (1985) Metabolite channeling: a phosphorylcreatine shuttle to mediate high energy phosphate transport between sperm mitochondrion and tail. Cell 41, 325-334
25. Jaynes, J. B., Chamberlain, J. S., Buskin, J. N., Johnson, J. E., and Hauschka, S. D. (1986) Transcriptional regulation of the muscle creatine kinase gene and regulated expression in transfected mouse myoblasts. Mol. Cell. Biol. 6, 2855-2864
26. Wallimann, T., Walzthöny, D., Wegmann, G., Moser, H., Eppenberger, H. M., and Barrantes, F. J. (1985) Subcellular localization of creatine kinase in Torpedo electrocytes: association with acetylcholine receptor-rich membranes. J. Cell Biol. 100, 1063-1072
27. Wallimann, T., and Hemmer, W. (1994) Creatine kinase in nonmuscle tissues and cells. Mol. Cell. Biochem. 133-134, 193-220
28. Haberland, M., Arnold, M. A., McAnally, J., Phan, D., Kim, Y., and Olson, E. N. (2007) Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation. Mol. Cell. Biol. 27, 518-525
29. Potthoff, M. J., Wu, H., Arnold, M. A., Shelton, J. M., Backs, J., McAnally, J., Richardson, J. A., Bassel-Duby, R., and Olson, E. N. (2007) Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J. Clin. Invest. 117, 2459-2467
30. Han, J., and Molkentin, J. D. (2000) Regulation of MEF2 by p38MAPKand its implication in cardiomyocyte biology. Trends Cardiovasc. Med. 10, 19-22
31. Lin, Q., Lu, J., Yanagisawa, H., Webb, R., Lyons, G. E., Richardson, J. A., and Olson, E. N. (1998) Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 125, 4565-4574
32. Passier, R., Zeng, H., Frey, N., Naya, F. J., Nicol, R. L., McKinsey, T. A., Overbeek, P., Richardson, J. A., Grant, S. R., and Olson, E. N. (2000) CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105, 1395-1406
33. Khurana, S., Chakraborty, S., Zhao, X., Liu, Y., Guan, D., Lam, M., Huang, W., Yang, S., and Kao, H. Y. (2012) Identification of a novel LXXLL motif in actinin 4-spliced isoform that is critical for its interaction with estrogen receptor and co-activators. J. Biol. Chem. 287, 35418-35429
34. Albagli-Curiel, O., Carnac, G., Vandromme, M., Vincent, S., Crépieux, P., and Bonnieu, A. (1993) Serum-induced inhibition of myogenesis is differentially relieved by retinoic acid and triiodothyronine in C2 murine muscle cells. Differentiation 52, 201-210
35. Cassar-Malek, I., Marchal, S., Altabef, M., Wrutniak, C., Samarut, J., and Cabello, G. (1994) v-erbA stimulates quail myoblast differentiation in a T3 independent, cell-specific manner. Oncogene 9, 2197-2206
36. Cassar-Malek, I., Marchal, S., Rochard, P., Casas, F., Wrutniak, C., Samarut, J., and Cabello, G. (1996) Induction of c-Erb A-AP-1 interactions and c-Erb A transcriptional activity in myoblasts by RXR: consequences for muscle differentiation. J. Biol. Chem. 271, 11392-11399